Table 2.
Percent of patients requiring surgery (ALOS) | Percent of patients requiring chemotherapy (ALOS) | Percent of patients requiring radiotherapy (ALOS) | |
---|---|---|---|
Gynecological cancers | 57 (6.5) | 67 (3) | 40 (5) |
Cervix uteri | 20 (5) | 80 (3) | 80 (5) |
Corpus uteri | 80 (5) | 20 (3) | 20 (5) |
Ovary | 70 (9) | 100 (3) | 20 (5) |
Head and neck cancers | 44 (7) | 66 (3.5) | 71 (5) |
Larynx | 50 (9) | 50 (3) | 75 (5) |
Lip and oral cavity | 40 (9) | 80 (3) | 80 (5) |
Nasopharynx | 0 (0) | 100 (3) | 100 (5) |
Other pharynx | 40 (9) | 80 (3) | 80 (5) |
Thyroid | 90 (7) | 20 (5) | 20 (5) |
Hematological malignancies | 0 (0) | 100 (6.5) | 33 (5) |
Hodgkin’s lymphoma | 0 (0) | 100 (5) | 40 (5) |
Leukemia | 0 (0) | 100 (7) | 20 (5) |
Multiple myeloma | 0 (0) | 100 (7) | 20 (5) |
Non-Hodgkin’s lymphoma | 0 (0) | 100 (7) | 50 (5) |
Urological cancers | 74 (8) | 63 (3.5) | 41 (5) |
Bladder | 100 (9) | 50 (3) | 50 (5) |
Kidney | 75 (9) | 50 (3) | 20 (5) |
Prostate | 20 (9) | 50 (3) | 65 (5) |
Testis | 100 (5) | 100 (5) | 30 (5) |
Brain and nervous system cancers | 100 (9) | 100 (3) | 100 (5) |
Breast cancers | 100 (5) | 100 (3) | 100 (5) |
Colorectal cancers | 70 (9) | 90 (3) | 25 (5) |
Gallbladder cancers | 33 (9) | 66 (3) | 50 (5) |
Kaposi’s sarcoma | 0 (0) | 70 (3) | 50 (5) |
Liver cancers | 5 (10) | 20 (3) | 20 (5) |
Lung cancers | 25 (10) | 50 (3) | 90 (5) |
Melanoma of the skin | 100 (3) | 50 (3) | 50 (5) |
Esophagus cancers | 20 (9) | 90 (3) | 90 (5) |
Pancreas cancers | 10 (10) | 50 (5) | 50 (5) |
Stomach cancers | 33 (5) | 66 (3) | 50 (5) |
It was assumed that for surgery or chemotherapy, all patients required hospitalization initially whereas for radiotherapy only one-quarter required hospitalization.